Skip to main content
Clinical Trials/CTRI/2024/12/078764
CTRI/2024/12/078764
Not yet recruiting
Phase 2/3

Preclinical and Clinical Study to Evaluate the Vranaropana Karma (Wound Healing Activity) of Sarala (Pinus roxburghii Sargent) Exudate

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital1 site in 1 country20 target enrollmentStarted: January 20, 2025Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Enrollment
20
Locations
1
Primary Endpoint
The safety and clinical efficacy of the test drug by monitoring the wound area, wound appearance, TC, DC, ESR, Hb%

Overview

Brief Summary

This clinical study, which will take place at the OPD of the IPGAER at SVSP Hospital, is a randomized, parallel-grouped control trial of a test drug comparing the safety and efficacy of Mupirocin for 28days in 20 patients suffering from different type of wounds. The primary outcome of this research is to evaluate the therapeutic efficacy of the test drug for its potential wound healing activity. The secondary outcome is to determine the safety of the test drug on quality of life among the patients suffering from different dermal injury.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • The clinical study will be single blind clinical study, with two groups of patients (male and female both) suffering from acute wound, partial fistulectomy wound in the OPD and IPD of the hospital at IPGAER, Kolkata.

Exclusion Criteria

  • Age below 20years or above 60years
  • Pre-existing diabetes mallitus
  • History of severe trauma
  • Pregnancy and lactating mother
  • Excessive P/R bleeding
  • Sexually transmitted disease
  • Malignancy
  • Patient with H/O multiple surgical intervention.

Outcomes

Primary Outcomes

The safety and clinical efficacy of the test drug by monitoring the wound area, wound appearance, TC, DC, ESR, Hb%

Time Frame: 28 days

Secondary Outcomes

  • Safe, Effective, Economical wound healing ayurvedic drug for the suffering patients(28 days)

Investigators

Sponsor
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Amit Kumar Taraphdar

Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital

Study Sites (1)

Loading locations...

Similar Trials